Font Size

SCREEN

Profile

Direction

Menu Style

In Brief
  1. ISIRV Journal: IRV Journal impact factor is now 4.4
  2. OPTIONS XII 29 Sept-2 Oct 2024 Brisbane, Australia
OPTIONS for the Control of Influenza XII

Anne Kelso, Director, WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Australia

anne kelso

Country of Residence: Australia

After obtaining her PhD in immunology at the University of Melbourne, Anne Kelso undertook research on cell-mediated immunity at the Swiss Institute for Experimental Cancer Research in Lausanne, the Walter and Eliza Hall Institute of Medical Research in Melbourne and the Queensland Institute of Medical Research in Brisbane. From 2000 until 2006, she was also Director of the Australian Government-funded Cooperative Research Centre for Vaccine Technology, a joint venture of eight academic and industry partners that developed new prototype vaccines and vaccine delivery technologies. In 2007 Professor Kelso returned to Melbourne as Director of the WHO Collaborating Centre for Reference and Research on Influenza where she oversees the Centre’s virological surveillance for the WHO Global Influenza Surveillance and Response System. She also holds an honorary professorial appointment in the Department of Microbiology and Immunology at the University of Melbourne where she is part of a collaborative research team working on T cell immunity to influenza viruses.
 

Professor Kelso has previously served as President of the Australasian Society for Immunology and as Secretary-General of the International Union of Immunological Societies and is currently member of a number of institute governing boards and other committees, including the Council of the Australian National Health and Medical Research Council and committees advising the Australian Government on influenza.